Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel
Clinical trial NCT02439346 · TERMINATED
Trial details
- NCT number
- NCT02439346
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-15
- Primary completion
- 2017-03-27
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.